MyFinsight
Home
Blog
About
Proceeds from sale of
common stock
$650K
Proceeds from sale of
exotropin interests
$376K
Net cash provided by
(used in) financing...
$642K
Net cash provided by
financing activities
$312K
Canceled cashflow
$8K
Canceled cashflow
$64K
Increase (decrease) in
cash
$816K
Canceled cashflow
$138K
Payments on finance
leases
$8K
Purchase of fixed assets
$64K
Stock-based compensation
$590K
Accounts payable and
accrued expenses
$236K
Deferred revenue
$37K
Depreciation and
amortization expense
$19K
Change in obligation to
repurchase shares
$17K
Amortization of oid and
commitment fee discount ...
$2K
Net cash used in
operating activities
-$138K
Canceled cashflow
$901K
Gain on sale of
exotropin interests
-$390K
Inventories
$234K
Accounts receivable, net
of allowance for...
$214K
Net loss
-$145K
Prepaid expenses
$45K
Security deposits
-$11K
Back
Back
Cash Flow
Zeo ScientifiX, Inc. (ZEOX)
Zeo ScientifiX, Inc. (ZEOX)
source: myfinsight.com